Lin Sun

Director/Miembro de la Junta en Hrain Biotechnology Co., Ltd. .

51 años

Consumer Services

Health Technology

Perfil

Lin Sun is an Independent Director at Hrain Biotechnology Co., Ltd.
since 2021.
Dr. Sun obtained a doctorate degree from National Taras Shevchenko University of Kiev in 2002.

Cargos activos de Lin Sun

Empresas	Cargo	Inicio
Hrain Biotechnology Co., Ltd. Hrain Biotechnology Co., Ltd. BiotechnologyHealth Technology Hrain Biotechnology Co., Ltd. engages in the research and development, and production of immune cell therapy products. It offers chimeric antigen receptor (CAR) T-cell therapy, chimeric antigen receptor-transduced natural killer (CAR-NK) cell therapy, dash chimeric antigen receptor (CAR) T-cell therapy. The company was founded by Pin Wang on July 20, 2015 and is headquartered in Shanghai, China.	Director/Miembro de la Junta	18/06/2021

Todos los cargos activos de Lin Sun

Formación de Lin Sun.

National Taras Shevchenko University of Kiev

Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Lin Sun.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	1
Hrain Biotechnology Co., Ltd. Hrain Biotechnology Co., Ltd. BiotechnologyHealth Technology Hrain Biotechnology Co., Ltd. engages in the research and development, and production of immune cell therapy products. It offers chimeric antigen receptor (CAR) T-cell therapy, chimeric antigen receptor-transduced natural killer (CAR-NK) cell therapy, dash chimeric antigen receptor (CAR) T-cell therapy. The company was founded by Pin Wang on July 20, 2015 and is headquartered in Shanghai, China.	Health Technology